A Study to Assess the Impact of Speed and Site of Subcutaneous Injection on Pain, Tolerability, Safety, and Pharmacokinetics of Gantenerumab in Healthy Participants
Clinical trial NCT02882009 · COMPLETED
Trial details
- NCT number
- NCT02882009
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-08-31
- Primary completion
- 2017-03-22
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.